Navigation Links
Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged Conference
Date:9/9/2009

CARLSBAD, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the Morgan Stanley Global Healthcare Unplugged Conference on Monday, September 14, 2009, at 1:35 p.m. ET at the Grand Hyatt New York.

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular, metabolic and severe neurodegenerative diseases and cancer. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis and Alnylam Pharmaceuticals are joint owners of Regulus Therapeutics Inc., a company focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at '/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 With crowded ... more popular. But according to Mike Whitfield, a bodyweight ... of equipment like the medicine ball can add a ... Whitfield runs BodyweightTorch.com, a website in which anyone can ... uses no equipment. Recently, he shared a video with ...
(Date:5/23/2013)... Studies show that kids and teens who ... less likely to be overweight, less likely to engage in ... have better relationships with their parents. , Despite ... family dinner expert and advocate Aviva Goldfarb . Over ... percent. When families do eat together, average mealtimes last a ...
(Date:5/23/2013)... May 23, 2013 Dr. Garber's ... condition specific remedies are now available at Whole Foods ... CA 92677. The line of natural biotherapy formulas continues ... Chain. , Represented by Brandstorm HBC (Los Angeles, CA), ... Markets throughout California, Nevada and Arizona, as well as ...
(Date:5/23/2013)... Brad Schmett, Broker Associate with Luxury Homes ... Palm Springs area real estate market will ... of the Annual Memorial Day Flower Drop at the ... , Culminating the festive three-day weekend, Valley residents will ... with flight exhibitions. However, the highlight of the Memorial ...
(Date:5/23/2013)... 23, 2013 To help members ... Walkingspree is pleased to announce integration of its ... devices. This new upgrade automatically transfers real-time step ... to track their company’s team standings, view progress ... fat burned. , Walkingspree also offers an integrated ...
Breaking Medicine News(10 mins):Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2Health News:Annual Memorial Day Flower Drop Honors Veterans in Palm Springs California by Brad Schmett 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3
... special clinic on wheels is being launched for sex ... treatment for sexually transmitted// disease along with blood test ... mobile clinic that would provide blood test facilities, treatment ... of sex workers for free is being launched here ...
... Indonesia's Bogor Institute of Agriculture have announced a joint ... for animals. The company to be called IPB Shigeta ... vaccine in a very short time. ,U.S.-based ... company to use its patented reverse genetics technology to ...
... friendly 7-year-old at Shaughnessy Elementary School died on Tuesday due ... had fever and headache and was sent home by the ... up and she did not budge she was taken to ... pronounced dead. She is the first child under 12 to ...
... even after eight days//. Now resident doctors from hospitals have ... in the city. ,Resident doctors in lab coats, ... to appeal to the public. Doctors from JJ hospital, KEM ... Mumbaikars on their way to work. ,The Doctor ...
... Hospitals trust is going to cut off nearly 300 jobs ... funding formula that incurred huge losses. //Royal Cornwall Hospitals Trust ... debts of ?8.1 million which might force it to ... ,Market Forces Factor (MFF) has perhaps caused this downslide, ...
... Institute for Health Information (CIHI) said that despite the ... been no shortening of waiting time. // Glenda Yeates, ... of diagnostic tests and high-priority procedures has increased dramatically. ... increased just as much. Statistics show that the number ...
Cached Medicine News:Health News:Mobile Clinic For Sex Workers In Pune 2
(Date:5/23/2013)... and DRESDEN, Germany , ... BioScience, a leading preclinical contract research provider and ... content-driven pharmacology, and Debiopharm Group™ (Debiopharm), a Swiss-based ... on the development of prescription drugs that target ... today announced that they have signed a research ...
(Date:5/22/2013)... 22, 2013  Aribex, Inc., manufacturer of the newly ... a new color option, black with gray trim, of ... veterinary markets. The popular white with light blue trim ... to be available and both models can be purchased ... (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are ...
(Date:5/22/2013)... 22, 2013 Advanced Prenatal Therapeutics (APT), a ... will help alleviate the high blood pressure and other ... expected to be the first medical device specifically designed ... fetal death. Every year, preeclampsia affects approximately ... . It is characterized by high blood pressure ...
Breaking Medicine Technology:Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 2Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 3Cenix BioScience and Debiopharm Group Collaborate to Identify Predictive Biomarkers 4Aribex Unveils New Color of NOMAD Pro 2 2Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... March 2, 2011 InspireMD ... system , has expanded its MGuard production facilities to ... behind the accelerating demand for MGuard include the recent ... protection to be considered for PCI of highly thrombotic ...
... 2011 Accumetrics, Inc., a privately-held developer and marketer ... point-of-care diagnostic system for measuring platelet reactivity to multiple ... an agreement with Portola Pharmaceuticals, Inc. to develop and ... clinical trials. The VerifyNow System is widely ...
Cached Medicine Technology:InspireMD Boosts MGuard Production Capacity 2Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc. 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: